Benzquinamide
Benzquinamide.svg
Clinical data
Trade namesPromecon, Quantril, Emete-Con
License data
Routes of
administration
Suppository, injection
ATC code
  • none
Identifiers
  • 3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate
CAS Number
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H32N2O5
Molar mass404.507 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C
  • InChI=InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3 ☒N
  • Key:JSZILQVIPPROJI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Benzquinamide is a discontinued antiemetic drug used in post-operative care. It was first synthesised by Pfizer in the 1960s.[1] [2]

References

  1. ^ Scriabine A, Weissman A, Finger KF (1963). "Benzquinamide". JAMA. 184 (4): 276–279. doi:10.1001/jama.1963.73700170001010. ISSN 0098-7484. PMID 13992595.
  2. ^ E.I. Goldenthal (1971). "A compilation of LD50 values in newborn and adult animals". Toxicol. Appl. Pharmacol. 18 (1): 185–207. doi:10.1016/0041-008X(71)90328-0. PMID 5542824.